Alopecia areata trials in United States

In United States 18 Also abroad 44

18 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Where
Bethesda
Age
12 years to 75 years
People
70
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05398809
Phase 3Taking people
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Where
Bexley, Birmingham, Boca Raton, Charleston, Charlotte, Chicago, Cincinnati, Clarkston, Cleveland, Coral Gables, Dallas, Doral, Encinitas, Exton, Fairfield, Grapevine, Hollywood, Indianapolis, Jacksonville, Los Angeles, Macon, Madison, Miami, Minneapolis, Murfreesboro, Murray, Norfolk, Omaha, Portland, Rockville, Saint Joseph, San Antonio, San Diego, San Francisco, Santa Ana, Scottsdale, Skokie, South Bend, Sugar Land, The Bronx, Tulsa
Age
6 years to 17 years
People
595 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05723198 · EU 2022-502700-78-00
Phase 2Taking people
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Where
Boston, Cutler Bay, Fremont, Northridge, Portsmouth, San Antonio, Santa Clarita, South Jordan, Troy
Age
18 years to 60 years
People
65 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07533006 · EU 2025-524727-41-00
Phase 3Taking people
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
Where
El Paso, Fairborn, Indianapolis, Los Angeles, Meridian, Miami, Norfolk, Omaha, San Antonio
Age
6 years to 17 years
People
300 worldwide
Run by
AbbVie
See details and how to joinNCT07772492 · EU 2025-525048-16-00
Phase 3Taking people
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Where
Baltimore, Bexley, Boston, Chapel Hill, Charlotte, Encinitas, Houston, Indianapolis, Iowa City, Miami, Plymouth Meeting, Portland, San Antonio, Skokie, Spokane, Troy
Age
12 years and over
People
336 worldwide
Run by
Pfizer
See details and how to joinNCT07733765
Phase 3Taking people
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Where
Arlington, Baltimore, Bellaire, Bexley, Birmingham, Boston, Brea, Canton, Chapel Hill, Charleston, Charlotte, Chicago, Dallas, Encinitas, Fairfield, Fort Myers, Glenn Dale, Hot Springs, Houston, Huntington Beach, Indianapolis, Iowa City, Irvine, Lake Bluff, Layton, Miami, Minneapolis, Murray, Myrtle Beach, New York, Northbrook, Plymouth Meeting, Portland, Rockville, San Antonio, Santa Ana, Skokie, Spokane, Tampa, Troy, Tulsa, Webster
Age
12 years and over
People
674 worldwide
Run by
Pfizer
See details and how to joinNCT06873945 · EU 2024-519370-40-00
Phase 3Taking people
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Where
Arlington, Bay City, Bellaire, Birmingham, Boca Raton, Boston, Brandon, Burlington, Caledonia, Canton, Cedar Park, Charleston, Chicago, Clarkston, Cleveland, Clinton Township, Columbus, Coral Gables, Dallas, Dawsonville, Detroit, Doral, Encino, Fort Smith, Fountain Valley, Glendale, Hollywood, Houston, Huntersville, Indianapolis, Irvine, Las Vegas, Leawood, Lee's Summit, Lincoln, Los Angeles, Margate, Marietta, Marriottsville, Mason, Miami, Minneapolis, Morgantown, Murfreesboro, New Brighton, New City, New Orleans, New York, Omaha, Phoenix, Pittsburgh, Portland, Rapid City, Redwood City, Reno, Sacramento, San Antonio, Sanford, Skokie, Spartanburg, Spokane, Springfield, Sugar Land, Tamarac, Tampa, Thousand Oaks
Age
12 years to 63 years
People
1,500 worldwide
Run by
AbbVie
See details and how to joinNCT06012240 · EU 2023-505061-82-01
Phase 2Taking people
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Where
New York
Age
12 years and over
People
56
Run by
Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07242638
Phase 3Taking people
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Where
Albuquerque, Aurora, Austin, Charleston, Corpus Christi, El Paso, Hershey, Indianapolis, Irvine, Marriottsville, Miami, Milwaukee, Omaha, Pflugerville, Portland, San Antonio, Santa Ana, Skokie, Washington D.C., Waterford
Age
6 years to 14 years
People
140 worldwide
Run by
Pfizer
See details and how to joinNCT07029828 · EU 2024-515439-31-00
Phase 1Taking people
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Where
Columbus, Indianapolis, Tampa
Age
18 years to 70 years
People
30
Run by
HCW Biologics
See details and how to joinNCT07049328
No phaseNot yet taking people in United States
An Observational Study of Patients With Dermatologic Disease
Where
New York
People
2,000,000
Run by
Target PharmaSolutions, Inc.
See details and how to joinNCT07748169
Phase 2Taking people
Dupilumab in the Treatment of Pediatric Alopecia Areata
Where
Chicago, Irvine, New York, San Diego
Age
6 years to 17 years
People
76
Run by
Icahn School of Medicine at Mount Sinai
See details and how to joinNCT05866562
No phaseTaking people
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Where
Waltham
Age
12 years to 17 years
People
1,500
Run by
CorEvitas
See details and how to joinNCT06562270
Phase 2Taking people
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Where
Minneapolis
Age
18 years to 75 years
People
40
Run by
University of Minnesota
See details and how to joinNCT06747611
Phase 2Taking people
Regeneron AA Multicenter (Dupilumab)
Where
Irvine, New York, Rochester
Age
18 years and over
People
76
Run by
Emma Guttman
See details and how to joinNCT05551793
Phase 2Taking people
A Study of LAD603 in Adults With Alopecia Areata
Where
Omaha
Age
18 years to 65 years
People
136 worldwide
Run by
Almirall, S.A.
See details and how to joinNCT07311564 · EU 2025-523342-27-00
No phaseTaking people
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Where
Waltham
Age
18 years and over
People
5,000
Run by
CorEvitas
See details and how to joinNCT05745389
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Where
Auburn Hills, Bakersfield, Birmingham, Boise, Bryant, Cary, Charlotte, Chicago, Clarksville, Cumming, Dallas, Denver, Doral, Fremont, Frisco, Greenville, Hollywood, Indianapolis, Kissimmee, Los Angeles, Louisville, Lynnwood, Macon, Mason, Miami, Miami Lakes, Missoula, Omaha, Palm Springs, Pflugerville, Plymouth Meeting, Pompano Beach, Rockville, Saint Joseph, San Antonio, San Diego, Sanford, Savannah, Scottsdale, Smyrna, South Jordan, Springville, Sweetwater, Troy, Verona, Wheat Ridge, Woodbury
Age
12 years to 17 years
People
355 worldwide
Run by
Sun Pharmaceutical Industries, Inc.
See details and how to joinNCT07133308